Tag Archives: JAZZ

Top 5 Performing Stocks To Watch Right Now

Some money managers are increasingly nervous about an upcoming recession amid higher interest rates and tighter credit availability.

“It’s a classical late cycle story. So, when I was here last time, I said we were long and nervous. We are no longer long, we are increasingly nervous about this,” Roelof Salomons, chief strategist at Kempen Capital Management, told CNBC’s “Squawk Box Europe” on Thursday.

A late cycle represents an economy that has been growing, but is poised to fall into a recession, amid tighter credit availability, lower profit margins and tighter monetary policy.

show chapters

We’re in a ‘classical late cycle story,’ strategist says    5 Hours Ago | 02:50

According to Salomons, the evidence for a late cycle is all there: the yield curve is flattening, which usually predicts an upcoming recession; the credit spreads are widening, suggesting that investors are afraid of taking risks; and defensive stocks are outperforming, which are a safer option to survive changes in the economic cycle.

Top 5 Performing Stocks To Watch Right Now: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Jazz Pharmaceuticals (JAZZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribers]

    Jazz Pharmaceuticals PLC  (NASDAQ:JAZZ)Q4 2018 Earnings Conference CallFeb. 26, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Jazz Pharmaceuticals (JAZZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)’s share price hit a new 52-week high and low during mid-day trading on Tuesday . The company traded as low as $173.93 and last traded at $172.72, with a volume of 22282 shares. The stock had previously closed at $172.50.

  • [By Money Morning News Team]

    Jazz Pharmaceuticals Plc. (Nasdaq: JAZZ) is a biotech company that is set up for strong growth thanks to its introduction of six new drugs into the market.

Top 5 Performing Stocks To Watch Right Now: Century Aluminum Company(CENX)

Advisors’ Opinion:

  • [By ]

    You can see why Century Aluminum (Nasdaq: CENX) commended the President for “acting swiftly and boldly to save the American aluminum industry.” The company intends to ramp up operations at its smelter in Hawesville, Kentucky, putting 300 people back to work. In Illinois, US Steel (NYSE: X) is restarting a blast furnace that will employ at least 500 new workers.

  • [By Matthew DiLallo]

    Shares of Century Aluminum Co (NASDAQ:CENX) are plunging today, down 14% as of 11:03 a.m. EDT, after Norsk Hydro (NASDAQOTH:NHYDY) shut down an alumina refinery in Brazil. That news sent the price of aluminum to a three-month high, which boosted Alcoa (NYSE:AA) stock. 

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Check-Cap Ltd. (NASDAQ: CHEK) shares dipped 47.8 percent to $4.60. Check-Cap priced its upsized underwritten offering of public units at $5.50 per unit.
    VivoPower International PLC (NASDAQ: VVPR) shares fell 41.5 percent to $2.57.
    Universal Electronics Inc. (NASDAQ: UEIC) dropped 35.1 percent to $29.50 after the company posted downbeat quarterly results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) dropped 34.8 percent to $3.75 after climbing 155.56 percent on Thursday.
    Integrated Media Technology Limited (NASDAQ: IMTE) fell 25.2 percent to $24.01 after surging 46.29 percent on Thursday.
    Fluor Corporation (NYSE: FLR) dropped 22.5 percent to $45.73 after the company reported downbeat earnings for its first quarter and lowered its profit outlook for the year.
    AMN Healthcare Services, Inc (NYSE: AMN) shares fell 19.6 percent to $52.075 following Q1 earnings.
    Adverum Biotechnologies, Inc. (NASDAQ: ADVM) shares declined 18.1 percent to $5.20. Adverum Biotech disclosed that its CEO Amber Salzman is stepping down.
    Newater Technology, Inc. (NASDAQ: NEWA) dropped 17.2 percent to $12.83.
    Basic Energy Services, Inc. (NYSE: BAS) fell 17.2 percent to $13.65 following Q1 results.
    Xperi Corporation (NASDAQ: XPER) declined 15.8 percent to $19.40 after announcing Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares fell 15.1 percent to $3.649 after climbing 22.16 percent on Thursday.
    Performant Financial Corporation (NASDAQ: PFMT) dropped 14.2 percent to $2.65.
    Gogo Inc. (NASDAQ: GOGO) shares fell 13.2 percent to $8.32 after the company reported Q1 results and disclosed that it is withdrawing its FY18 outlook for adjusted EBITDA, airborne cash capex, airborne equipment inventory purchases and free cash flow.
    Technical Communications Corporation (NASDAQ: TCCO) dropped 12.2 percent to $5.05.
    Web.com Group, Inc. (NASDAQ: WEB) fell 9.7 percent

  • [By D.R. Barton, Jr.]

    According to industry leaders, including Century Aluminum Co. (Nasdaq: CENX) CEO Michael Bless, many of those jobs will be in jeopardy with the new taxes. And then there’s the reciprocal tariff reactions from other nations that would definitely hit the billions of dollars’ worth of U.S. agricultural exports with further jobs in jeopardy.

  • [By Alexander Bird]

    Aluminum producer Century Aluminum Co. (Nasdaq: CENX) added 3.3%to its share price, and Alcoa Corp. (NYSE: AA) edged up 0.2%, both closing out the day with gains.

Top 5 Performing Stocks To Watch Right Now: Lazard Global Total Return and Income Fund(LGI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Headlines about Lazard Global Total Return & Income Fund common stock (NYSE:LGI) have been trending somewhat negative recently, Accern Sentiment Analysis reports. Accern ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Lazard Global Total Return & Income Fund common stock earned a news sentiment score of -0.13 on Accern’s scale. Accern also gave media coverage about the company an impact score of 47.0546102091578 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Top 5 Performing Stocks To Watch Right Now: NETGEAR, Inc.(NTGR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    ValuEngine upgraded shares of Netgear (NASDAQ:NTGR) from a hold rating to a buy rating in a research report sent to investors on Wednesday.

    A number of other equities analysts have also weighed in on the stock. Zacks Investment Research lowered shares of Netgear from a strong-buy rating to a strong sell rating in a research report on Wednesday. Guggenheim reiterated a buy rating and issued a $76.00 price target on shares of Netgear in a research report on Friday, April 27th. BidaskClub upgraded shares of Netgear from a buy rating to a strong-buy rating in a research report on Saturday, January 13th. Finally, BWS Financial set a $75.00 price target on shares of Netgear and gave the stock a buy rating in a research report on Friday, January 12th. One research analyst has rated the stock with a sell rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of Buy and a consensus price target of $73.20.

  • [By Max Byerly]

    ValuEngine upgraded shares of NetGear (NASDAQ:NTGR) from a hold rating to a buy rating in a research report sent to investors on Tuesday morning.

    Other analysts also recently issued research reports about the stock. BidaskClub downgraded shares of NetGear from a strong-buy rating to a buy rating in a research report on Tuesday, June 26th. TheStreet downgraded shares of NetGear from a b- rating to a c+ rating in a research report on Monday, August 13th. Raymond James set a $80.00 target price on shares of NetGear and gave the stock a buy rating in a research report on Wednesday, September 5th. Cowen assumed coverage on shares of NetGear in a research report on Monday. They set a hold rating and a $63.00 target price for the company. Finally, Zacks Investment Research raised shares of NetGear from a strong sell rating to a hold rating in a research report on Wednesday, June 27th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the company’s stock. The company presently has an average rating of Hold and an average price target of $70.40.

  • [By Joseph Griffin]

    Shares of NetGear, Inc. (NASDAQ:NTGR) reached a new 52-week high during trading on Tuesday after BidaskClub upgraded the stock from a buy rating to a strong-buy rating. The company traded as high as $72.30 and last traded at $71.55, with a volume of 8070 shares traded. The stock had previously closed at $70.10.

  • [By Steve Symington]

    Shares of Netgear (NASDAQ:NTGR) fell 11.3%% in September, according to data from S&P Global Market Intelligence, in lockstep with the post-earnings decline of recent spinoff Arlo Technologies (NYSE:ARLO).

  • [By Max Byerly]

    Netgear (NASDAQ:NTGR) has received a consensus recommendation of “Buy” from the seven brokerages that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, five have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $74.50.

  • [By Steve Symington]

    Shares of Netgear Inc. (NASDAQ:NTGR) fell 10.6% today after the networking hardware specialist delivered strong first-quarter 2018 results but followed with underwhelming guidance.

Top 5 Performing Stocks To Watch Right Now: SL Green Realty Corporation(SLG)

Advisors’ Opinion:

  • [By Shane Hupp]

    Sterlingcoin (CURRENCY:SLG) traded down 0.7% against the dollar during the twenty-four hour period ending at 10:00 AM E.T. on September 8th. One Sterlingcoin coin can currently be bought for $0.0303 or 0.00000468 BTC on cryptocurrency exchanges. In the last seven days, Sterlingcoin has traded 26.6% lower against the dollar. Sterlingcoin has a total market cap of $128,686.00 and approximately $20.00 worth of Sterlingcoin was traded on exchanges in the last 24 hours.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on SL Green Realty (SLG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Sterlingcoin (SLG) is a proof-of-stake (PoS) coin that uses the
    X13 hashing algorithm. It was first traded on September 21st, 2014. Sterlingcoin’s total supply is 4,241,006 coins. Sterlingcoin’s official Twitter account is @SterlingcoinSLG and its Facebook page is accessible here. The Reddit community for Sterlingcoin is /r/sterlingcoin and the currency’s Github account can be viewed here. The official website for Sterlingcoin is sterlingcoin.org.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on SL Green Realty (SLG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Shares of SL Green Realty Corp (NYSE:SLG) have been given an average recommendation of “Hold” by the eighteen ratings firms that are presently covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a sell recommendation, six have given a hold recommendation and nine have given a buy recommendation to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $111.54.

  • [By Max Byerly]

    Sterlingcoin (CURRENCY:SLG) traded flat against the dollar during the one day period ending at 9:00 AM Eastern on October 1st. In the last week, Sterlingcoin has traded 3.1% higher against the dollar. One Sterlingcoin coin can currently be purchased for about $0.0337 or 0.00000516 BTC on exchanges. Sterlingcoin has a market capitalization of $143,001.00 and approximately $0.00 worth of Sterlingcoin was traded on exchanges in the last 24 hours.

Top 10 Performing Stocks To Own Right Now

Stocks continue to print new highs. And many continue to doubt the rally–as they have for much of the post-crisis recovery.

They continue to say stocks are priced for perfection, implying that stocks are expensive, and/or that investors are assuming a perfect presidency from Trump. But remember, we’ve talked about the massive fundamental and technical performance gap that has still yet to be closed, dating back to the 2007 pre-crisis peak. I did this analysis again just a few days after the election. You can see it here: “The Trump Effect Will Make Stocks Extraordinarily Cheap.”

Now, a few days ago, we talked about buying the stocks of the guests of Trump Tower. Goldman Sachs comes to mind, as the Wall Street powerhouse has been well represented in the Trump plan, including the new Treasury Secretary appointment. Goldman is the best performing Dow stock over the past month. And we talked about the meeting with Japanese investor, Masayoshi Son, at Trump Tower this week. Son’s gigantic (80%+) stake in Sprint is up 11% since Tuesday.

Top 10 Performing Stocks To Own Right Now: Blue Nile Inc.(NILE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    News headlines about Blue Nile (NASDAQ:NILE) have trended somewhat positive this week, Accern Sentiment reports. Accern ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Blue Nile earned a news sentiment score of 0.04 on Accern’s scale. Accern also gave media coverage about the company an impact score of 44.0484134103501 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Top 10 Performing Stocks To Own Right Now: iShares MSCI EAFE (EFA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Neumann Capital Management LLC increased its holdings in iShares MSCI EAFE ETF (NYSEARCA:EFA) by 41.2% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 65,172 shares of the exchange traded fund’s stock after buying an additional 19,013 shares during the period. iShares MSCI EAFE ETF comprises approximately 2.9% of Neumann Capital Management LLC’s holdings, making the stock its 11th biggest position. Neumann Capital Management LLC’s holdings in iShares MSCI EAFE ETF were worth $4,541,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Investors sold shares of iShares MSCI EAFE ETF (NYSEARCA:EFA) on strength during trading hours on Thursday. $135.72 million flowed into the stock on the tick-up and $204.09 million flowed out of the stock on the tick-down, for a money net flow of $68.37 million out of the stock. Of all equities tracked, iShares MSCI EAFE ETF had the 19th highest net out-flow for the day. iShares MSCI EAFE ETF traded up $0.46 for the day and closed at $65.99

  • [By Todd Shriber, ETF Professor]

    HEFA debuted in early 2014 as the currency hedged alternative to traditional MSCI EAFE strategies. HEFA is essentially the MSCI EAFE ETF (NYSE: EFA) with a currency hedged kicker. EFA, one of the largest developed market ETFs, is HEFA lone equity holding. HEFA has amassed $3.61 billion in assets since coming to market.

Top 10 Performing Stocks To Own Right Now: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Jazz Pharmaceuticals (JAZZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)’s share price hit a new 52-week high and low during mid-day trading on Tuesday . The company traded as low as $173.93 and last traded at $172.72, with a volume of 22282 shares. The stock had previously closed at $172.50.

  • [By Motley Fool Transcribers]

    Jazz Pharmaceuticals PLC  (NASDAQ:JAZZ)Q4 2018 Earnings Conference CallFeb. 26, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Performing Stocks To Own Right Now: Strategic Global Income Fund, Inc.(SGL)

Advisors’ Opinion:

  • [By Max Byerly]

    News headlines about Strategic Global Income Fund (NYSE:SGL) have trended somewhat positive on Monday, Accern Sentiment reports. The research group rates the sentiment of media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Strategic Global Income Fund earned a media sentiment score of 0.02 on Accern’s scale. Accern also gave news stories about the financial services provider an impact score of 46.9423274211809 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

  • [By Max Byerly]

    SGL Carbon (ETR:SGL) received a €14.00 ($16.28) target price from analysts at Baader Bank in a report released on Tuesday. The brokerage presently has a “neutral” rating on the stock. Baader Bank’s price objective would indicate a potential upside of 35.27% from the company’s current price.

Top 10 Performing Stocks To Own Right Now: AMAG Pharmaceuticals, Inc.(AMAG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on AMAG Pharmaceuticals (AMAG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    AMAG Pharmaceuticals (NASDAQ:AMAG) was upgraded by equities researchers at ValuEngine from a “hold” rating to a “buy” rating in a research note issued on Monday.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on AMAG Pharmaceuticals (AMAG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on AMAG Pharmaceuticals (AMAG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Own Right Now: Madison Square Garden Inc.(MSG)

Advisors’ Opinion:

  • [By Logan Wallace]

    Madison Square Garden Co (NYSE:MSG)’s share price hit a new 52-week high during trading on Thursday . The stock traded as high as $298.43 and last traded at $293.96, with a volume of 26154 shares trading hands. The stock had previously closed at $288.80.

  • [By Garrett Baldwin]

    Earnings season is well underway. And if you’re looking to make real money, the time to get started is now. Money Morning’s Quantitative Specialist Chris Johnson argues that the markets are at a tipping point. And with just a few smart plays in today’s classic stock picker’s market… you can pull in triple digit gains with just a small investment. Read those picks, right here.

    The Top Stock Market Stories for Thursday
    Wal-Mart Stores (NYSE: WMT) headlines a busy day of earnings reports Today. Shares of WMT stock popped almost 10% after the firm reported its largest domestic sales increase in 10 years. Walmart reported adjusted earnings of $1.29 per share, a figure that topped expectations by 7 cents per share. Revenue also easily beat Wall Street expectations. The firm’s positive earnings and revenue numbers helped push its rival Target Corporation (NYSE: TGT) up 3% as well before the bell Thursday. Turkey remains a major geopolitical headache for markets around the globe. The International Monetary Fund issued a statement arguing that the nation must take steps to stabilize its currency and help bring certainty to the global markets. The country’s currency (the Lira) is off about 40% this year as markets grow increasingly concerned about the nation’s leaders’ abilities to stave off inflation. President Tayyip Erdogan’s has repeated called for lower interest rates despite clear proof that the nation’s currency value is eroding.
    Four Stocks to Watch Today: NVDA, JCP, BA
    NVIDIA Corporation (Nasdaq: NVDA) will report earnings after the bell Thursday. Wall Street will be interested to learn the impact of falling Bitcoin and other cryptocurrency prices on the semiconductor giant’s bottom line. The average trade estimate for earnings sits at $1.83 per share on top of $3.11 billion in quarterly revenue. A day after news broke that U.S. retail spending was strong in the second quarter, J.C. Penney (NYSE: JCP) shares plunged nearly 22% after the firm reported

  • [By Steve Symington]

    But some individual companies enjoyed far greater gains. Read on to learn why McCormick (NYSE:MKC), CalAmp (NASDAQ:CAMP), and Madison Square Garden (NYSE:MSG) outperformed the market today.

  • [By Motley Fool Transcribers]

    The Madison Square Garden Co  (NYSE:MSG)Q2 2019 Earnings Conference CallFeb. 01, 2019, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Performing Stocks To Own Right Now: Sandstorm Gold Ltd(SAND )

Advisors’ Opinion:

  • [By Stephan Byrd]

    CIBC Asset Management Inc grew its stake in shares of Sandstorm Gold Ltd (NYSEAMERICAN:SAND) by 41.7% in the fourth quarter, HoldingsChannel.com reports. The firm owned 962,780 shares of the mining company’s stock after buying an additional 283,504 shares during the quarter. CIBC Asset Management Inc’s holdings in Sandstorm Gold were worth $4,458,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    Sandstorm Gold (NYSEAMERICAN:SAND) had its target price raised by analysts at Raymond James from $5.75 to $6.00 in a research report issued to clients and investors on Thursday. The brokerage currently has an “outperform” rating on the mining company’s stock. Raymond James’ price target points to a potential upside of 4.35% from the stock’s current price.

  • [By Joseph Griffin]

    Boston Partners purchased a new stake in Sandstorm Gold (NYSEAMERICAN:SAND) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 463,325 shares of the mining company’s stock, valued at approximately $2,205,000. Boston Partners owned about 0.25% of Sandstorm Gold as of its most recent filing with the Securities and Exchange Commission.

Top 10 Performing Stocks To Own Right Now: Innodata Inc.(INOD)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Media coverage about Innodata (NASDAQ:INOD) has trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Innodata earned a media sentiment score of 0.10 on Accern’s scale. Accern also gave news articles about the technology company an impact score of 47.3485759085159 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

  • [By Logan Wallace]

    Luzich Partners LLC lifted its stake in shares of Innodata Inc (NASDAQ:INOD) by 4.9% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,316,550 shares of the technology company’s stock after acquiring an additional 61,944 shares during the period. Innodata accounts for approximately 1.5% of Luzich Partners LLC’s portfolio, making the stock its 12th biggest position. Luzich Partners LLC owned about 5.09% of Innodata worth $1,514,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Innodata (NASDAQ:INOD) will be releasing its Q1 2018 earnings data before the market opens on Tuesday, May 8th.

    Innodata (NASDAQ:INOD) last announced its earnings results on Thursday, March 8th. The technology company reported ($0.02) earnings per share (EPS) for the quarter. The business had revenue of $15.66 million for the quarter. Innodata had a negative return on equity of 10.94% and a negative net margin of 8.30%.

Top 10 Performing Stocks To Own Right Now: Legacy Reserves LP(LGCY)

Advisors’ Opinion:

  • [By Shane Hupp]

    Legacy Reserves LP (NASDAQ:LGCY) hit a new 52-week high and low on Tuesday . The stock traded as low as $8.74 and last traded at $8.63, with a volume of 42189 shares. The stock had previously closed at $8.36.

  • [By Matthew DiLallo]

    Legacy Reserves (NASDAQ:LGCY) continued its torrid run on Wednesday, rising another 20% by 12:45 p.m. EDT after one of the company’s largest investors revealed the purchase of additional units. That brings the oil and gas producer’s year-to-date rally up over 250% as fears concerning its future have quickly faded alongside higher oil prices.

  • [By Matthew DiLallo]

    Shares of Legacy Reserves Inc. (NASDAQ:LGCY) rose more than 13% by 10:30 a.m. EDT on Friday after the oil and gas producer completed its planned corporate reorganization.

Top 10 Performing Stocks To Own Right Now: Denison Mine Corp(DNN)

Advisors’ Opinion:

  • [By Jim Robertson]

    Last Thursday, small cap uranium mining stock Denison Mines Corp (NYSEAMERICAN: DNN), which is also focused on the Athabasca Basin of Saskatchewan, reported 2017 earnings and gave its outlook for 2018 with the outlook coming with extensive commentary about the uranium market and Athabasca. David Cates, the President and CEO of Denison Mines Corp, gave the following commentary:

  • [By Scott Levine]

    Shares of Denison Mines (NYSEMKT:DNN), a uranium exploration and development company, climbed 28% in September, according to data from S&P Global Market Intelligence. In addition to the news that Denison intends to acquire 100% of Cameco’s interest in the Wheeler River Joint Venture, shareholders celebrated the reporting of favorable results from the company’s pre-feasibility study (PFS) conducted at Wheeler River. 

  • [By Reuben Gregg Brewer]

    Denison Mines (NYSEMKT:DNN) is working to build a new uranium mine in Canada. For investors interested in the nuclear fuel, it’s an interesting stock to look at because of the material upside potential if construction plans play out as projected and uranium prices rise. But does that make it a stock worth buying? Only if you clearly understand the risks before putting your hard-saved capital into the shares. Here are some key facts you need to know before you invest here.

  • [By Logan Wallace]

    Denison Mines (TSE:DML) (NYSE:DNN) had its price target upped by Raymond James from C$0.95 to C$1.25 in a research note issued to investors on Wednesday. Raymond James currently has a market perform rating on the stock.

Top 10 Heal Care Stocks To Invest In Right Now

Photo Credit: Quanta Services, Inc.

Timing Economic Expansion

Selecting stocks is a tough process in the best of times, but when the length of the U.S. economic expansion is nearing a record, investors need to look at how a company will perform in good times and bad. Different industries and companies fare better across the stages of the economic cycle, where stocks with lower risk, fewer ties to discretionary income, and less hype will outperform when the economy sours. Forecasting is more of an art than a science, but there are indicators that can be helpful in determining these turning points.

Top 10 Heal Care Stocks To Invest In Right Now: Etsy, Inc.(ETSY)

Advisors’ Opinion:

  • [By Rick Munarriz]

    Etsy (NASDAQ:ETSY) is one of this year’s biggest and more surprising winners. Shares of the arts and crafts marketplace operator have soared 147% in 2018. And it seems as if events that might sometimes be seen as bad news are being interpreted by the market as stock-propping positive developments. 

  • [By Max Byerly]

    Etsy Inc (NASDAQ:ETSY) – Investment analysts at DA Davidson increased their Q2 2019 earnings per share (EPS) estimates for Etsy in a note issued to investors on Tuesday, February 26th. DA Davidson analyst T. Forte now expects that the specialty retailer will post earnings per share of $0.20 for the quarter, up from their prior estimate of $0.16. DA Davidson currently has a “Buy” rating and a $71.00 target price on the stock. DA Davidson also issued estimates for Etsy’s Q3 2019 earnings at $0.19 EPS, Q4 2019 earnings at $0.31 EPS, FY2019 earnings at $0.86 EPS, FY2020 earnings at $1.34 EPS, FY2021 earnings at $1.68 EPS, FY2022 earnings at $2.23 EPS and FY2023 earnings at $2.79 EPS.

  • [By Stephan Byrd]

    SG Americas Securities LLC decreased its holdings in shares of Etsy Inc (NASDAQ:ETSY) by 20.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,061 shares of the specialty retailer’s stock after selling 2,063 shares during the quarter. SG Americas Securities LLC’s holdings in Etsy were worth $340,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    Etsy (NASDAQ:ETSY) has earned a consensus rating of “Buy” from the fifteen research firms that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company. The average 12 month target price among brokerages that have covered the stock in the last year is $26.54.

  • [By Shane Hupp]

    Etsy Inc (NASDAQ:ETSY) has earned a consensus rating of “Buy” from the fifteen brokerages that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, five have assigned a hold rating, six have assigned a buy rating and two have issued a strong buy rating on the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $44.15.

Top 10 Heal Care Stocks To Invest In Right Now: XOMA Corporation(XOMA)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Spark Investment Management LLC increased its stake in XOMA Corp (NASDAQ:XOMA) by 16.6% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 52,100 shares of the biotechnology company’s stock after purchasing an additional 7,400 shares during the quarter. Spark Investment Management LLC owned 0.62% of XOMA worth $1,087,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Here are some of the news articles that may have impacted Accern Sentiment Analysis’s analysis:

    Get XOMA alerts:

    Botulism Market Therapeutic Pipeline, H1 2018 Therapy Area, Drug Profile and Major Key Players (talkinvestor.com) Hypoglycemia Market Pipeline Review H1- Target Drug Profile, Top Industry Intelligence, Major Key Players and R&D … (expertherald.com) Hypoglycemia Market Research Report Pipeline Review H1 Assessment by Mechanism of Action, Drug Profile and … (trueindustrynews.com) Anterior Uveitis Market Pipeline Review Development by Therapy Area, Stage of Development and Indication (thefreenewsman.com) Zacks: Analysts Anticipate XOMA Corp (XOMA) Will Announce Quarterly Sales of $4.57 Million (americanbankingnews.com)

    Several equities research analysts recently issued reports on XOMA shares. Zacks Investment Research upgraded shares of XOMA from a “sell” rating to a “buy” rating and set a $27.00 price objective for the company in a research report on Wednesday, May 16th. HC Wainwright set a $49.00 price objective on shares of XOMA and gave the stock a “buy” rating in a research report on Thursday, May 10th. TheStreet upgraded shares of XOMA from a “d” rating to a “c-” rating in a research report on Tuesday, June 12th. Cowen restated a “hold” rating on shares of XOMA in a research report on Thursday, May 10th. Finally, ValuEngine upgraded shares of XOMA from a “sell” rating to a “hold” rating in a research report on Friday, March 9th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $36.33.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on XOMA (XOMA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

      

    Clearside Biomedical, Inc. (NASDAQ: CLSD) shares declined 32.19 percent to close at $9.86 on Thursday. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.
    scPharmaceuticals Inc. (NASDAQ: SCPH) shares dipped 30.1 percent to close at $9.94 on Thursday after the FDA identified deficiencies in the company’s New Drug Application for FUROSCIX. However, the FDA letter did not specify deficiencies identified and notification does not reflect final decision on information under review.
    Euroseas Ltd. (NASDAQ: ESEA) fell 24.08 percent to close at $1.86. Euroseas announced completion of the spin-off of its drybulk fleet into EuroDry Ltd.
    Golar LNG Limited (NASDAQ: GLNG) fell 25.09 percent to close at $25.98 following Q1 results.
    Oragenics, Inc. (NASDAQ: OGEN) shares dropped 25 percent to close at $1.50 on Thursday.
    Guess', Inc. (NYSE: GES) dropped 19.44 percent to close at $19.60 following Q1 results.
    Cantel Medical Corp. (NYSE: CMD) dropped 15.94 percent to close at $109.09 on Thursday following FQ3 results.
    Fusion Connect, Inc. (NASDAQ: FSNN) shares fell 15.55 percent to close at $3.91.
    Build-A-Bear Workshop, Inc. (NYSE: BBW) dropped 14.44 percent to close at $8.00 after reporting Q1 results.
    Dollar Tree, Inc. (NASDAQ: DLTR) shares declined 14.28 percent to close at $82.59 after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance.
    Titan Machinery Inc. (NASDAQ: TITN) dropped 13.94 percent to close at $18.09 after reporting Q1 results.
    Co-Diagnostics, Inc. (NASDAQ: CODX) declined 13.17 percent to close at $2.90 after declining 5.65 percent on Wednesday.
    Concordia International Corp. (NASDAQ: CXRX) fell 12.89 percent to close at $0.2440 after the company announced that it would be delisted from the Nasdaq.
    Sears Holdings Corporation (NASDAQ: SHLD) slipped 12.46 percent

Top 10 Heal Care Stocks To Invest In Right Now: Wendy’s/Arby’s Group Inc.(WEN)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion.
    Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion.
    The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion.
    Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million.
    Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion.
    LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion.
    Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion.
    TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million.
    The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million.
    A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion.
    Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million.
    Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million.
    ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million.
    KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13

  • [By Ethan Ryder]

    A.R.T. Advisors LLC lowered its stake in Wendys Co (NASDAQ:WEN) by 19.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 150,664 shares of the restaurant operator’s stock after selling 36,036 shares during the period. A.R.T. Advisors LLC owned 0.06% of Wendys worth $2,644,000 at the end of the most recent reporting period.

  • [By Rich Duprey]

    Buyout speculation gained momentum last week after The Wall Street Journal — citing anonymous “people familiar with the matter” — said Nelson Peltz and his Trian Fund Management hedge fund were contemplating a takeover offer for Papa John’s. Peltz also arranged a meeting between Schnatter and the management of burger joint Wendy’s (NASDAQ:WEN) in late June to discuss a possible deal, according to WSJ. However, Wendy’s backed away after the last Schnatter brouhaha.

  • [By Jeremy Bowman]

    The chart below shows how McDonald’s compares with some of its closest peers based on its valuation and expected growth rate.

    Company P/E Ratio 2-Year Expected EPS Growth Rate
    McDonald’s (NYSE:MCD) 26.2 23.6%
    Starbucks (NASDAQ:SBUX) 26.2 27.3%
    Wendy’s (NASDAQ:WEN) 21.8 58.1%
    Restaurant Brands International (NYSE:QSR) 21.4 41.9%
    Yum! Brands (NYSE:YUM) 23.2 29.7%

    Data source: Yahoo! Finance. EPS = earnings per share.

  • [By Matt Hogan]

    Growth within the industry is a bit lumpy, with limited-service restaurants, such as Wendys Co (NASDAQ: WEN) and Chipotle Mexican Grill, Inc (NYSE: CMG), growing at 5.3 percent in 2017 as compared to 3.5 percent for casual dining establishments according to the National Restaurant Industry.

Top 10 Heal Care Stocks To Invest In Right Now: AVEO Pharmaceuticals, Inc.(AVEO)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Here are some of the news articles that may have impacted Accern’s analysis:

    Get AVEO Pharmaceuticals alerts:

    AVEO Pharmaceuticals, Inc. (AVEO) Expected to Announce Quarterly Sales of $670,000.00 (americanbankingnews.com) Notable Stocks on the Move – AVEO Pharmaceuticals, Inc., (NASDAQ: AVEO) (nysenewstoday.com) AVEO Pharmaceuticals, Inc. (AVEO)- Profitability Ratios under Review (topdesertsafari.com) Buy And Hold, And Diversify: AVEO Pharmaceuticals, Inc. (AVEO), American International Group, Inc. (AIG) (nmsunews.com) Switching Stocks: AVEO Pharmaceuticals, Inc., (NASDAQ: AVEO), Graphic Packaging Holding Company, (NYSE: GPK) (nysetradingnews.com)

    NASDAQ AVEO traded up $0.10 on Tuesday, hitting $2.37. 1,781,596 shares of the company traded hands, compared to its average volume of 2,022,071. The company has a market capitalization of $277.34 million, a PE ratio of -14.81 and a beta of 1.55. The company has a debt-to-equity ratio of -0.36, a quick ratio of 1.16 and a current ratio of 1.16. AVEO Pharmaceuticals has a 52-week low of $1.86 and a 52-week high of $4.24.

  • [By Brian Orelli]

    Shares of AVEO Pharmaceuticals (NASDAQ:AVEO) jumped 40% in August, according to data provided by S&P Global Market Intelligence as investors jump in ahead of data from its phase 3 Tivo-3 clinical trial, which is expected in the fourth quarter.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on AVEO Pharmaceuticals (AVEO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Heal Care Stocks To Invest In Right Now: Information Services Group Inc.(III)

Advisors’ Opinion:

  • [By Joseph Griffin]

    RMR Group (NASDAQ: RMR) and Information Services Group (NASDAQ:III) are both finance companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

  • [By Logan Wallace]

    CGI Group (NYSE: GIB) and Information Services Group (NASDAQ:III) are both computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Information Services Group, Inc. Common Stock (III)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Martingale Asset Management L P bought a new position in Information Services Group, Inc. Common Stock (NASDAQ:III) during the second quarter, Holdings Channel reports. The fund bought 110,416 shares of the business services provider’s stock, valued at approximately $453,000.

Top 10 Heal Care Stocks To Invest In Right Now: Nucor Corporation(NUE)

Advisors’ Opinion:

  • [By ]

    Steel Dynamics (STLD) : “That’s a great steel company and the only one I’ll recommend other than Nucor (NUE) .”

    Sprint (S) : “I think you have to ring the register. All we have are rumors of a merger.”

  • [By Reuben Gregg Brewer]

    Nucor Corp.’s (NYSE:NUE) earnings more than doubled year over year in the second quarter, and were also up more than 90% sequentially. In fact, Nucor even outperformed its own expectations, and CEO John Ferriola noted that this was the strongest Q2 in the giant U.S. steel producer’s history.

  • [By Dan Caplinger]

    Some stocks are pretty predictable in terms of when they’ll increase their dividend payouts to their investors. Trying to give at least one boost per year is a goal that many companies strive for, and a select few have put together long streaks of annual dividend hikes year in and year out. For Nike (NYSE:NKE), Nucor (NYSE:NUE), and Lockheed Martin (NYSE:LMT), it would be a big surprise if shareholders didn’t see a dividend increase between now and year end.

  • [By ]

    America’s oil renaissance is powered almost exclusively by technology, as companies like Schlumberger (SLB) and Core Labs (CLB) are breathing new life into once forgotten wells. Nucor (NUE) has a similar leadership position in the steel industry thanks to technology, and that company will only benefit more that President Trump’s tariffs put the market on a more level playing field.

  • [By ]

    In short, this is a complicated mess for investors. As with any big decree from Washington, there will be both winners and losers. Nucor (NYSE: NUE) bolted to near $70 per share on the announcement before profit-taking set in. But others could see rising costs or falling demand. Midstream energy companies, for instance, are already seeking exemptions, as imported steel accounts for nearly 80% of U.S. oil and gas pipelines.

  • [By ]

    In the Lightning Round, Cramer was bullish on GTT Communications (GTT) , Steel Dynamics (STLD) , Nucor (NUE) , Marriott International (MAR) , MGM Resorts (MGM) and Twitter (TWTR) .

Top 10 Heal Care Stocks To Invest In Right Now: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Jazz Pharmaceuticals (JAZZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribers]

    Jazz Pharmaceuticals PLC  (NASDAQ:JAZZ)Q4 2018 Earnings Conference CallFeb. 26, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Money Morning News Team]

    Jazz Pharmaceuticals Plc. (Nasdaq: JAZZ) is a biotech company that is set up for strong growth thanks to its introduction of six new drugs into the market.

  • [By Max Byerly]

    Keybank National Association OH purchased a new position in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 2,808 shares of the specialty pharmaceutical company’s stock, valued at approximately $484,000.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Jazz Pharmaceuticals (JAZZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Heal Care Stocks To Invest In Right Now: Franklin Resources, Inc.(BEN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    New England Research & Management Inc. reduced its holdings in Franklin Resources, Inc. (NYSE:BEN) by 3.9% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 55,990 shares of the closed-end fund’s stock after selling 2,250 shares during the quarter. Franklin Resources comprises 1.2% of New England Research & Management Inc.’s portfolio, making the stock its 15th largest holding. New England Research & Management Inc.’s holdings in Franklin Resources were worth $1,794,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By WWW.GURUFOCUS.COM]

    For the details of Gallagher Fiduciary Advisors, LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Gallagher+Fiduciary+Advisors%2C+LLC

    These are the top 5 holdings of Gallagher Fiduciary Advisors, LLCFifth Third Bancorp (FITB) – 7,424,558 shares, 43.91% of the total portfolio. New PositionUnited States Steel Corp (X) – 3,763,643 shares, 25.82% of the total portfolio. Franklin Resources Inc (BEN) – 1,825,092 shares, 15.42% of the total portfolio. Shares reduced by 2.44%Cleveland-Cliffs Inc (CLF) – 1,780,977 shares, 2.5% of the total portfolio. Shares reduced by 1.33%Finisar Corp (FNSR) – 349,639 shares, 1.39% of t

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Franklin Resources (BEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    State of Alaska Department of Revenue increased its stake in shares of Franklin Resources, Inc. (NYSE:BEN) by 14.9% in the second quarter, HoldingsChannel reports. The firm owned 70,018 shares of the closed-end fund’s stock after buying an additional 9,084 shares during the quarter. State of Alaska Department of Revenue’s holdings in Franklin Resources were worth $2,243,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    NN Investment Partners Holdings N.V. trimmed its holdings in shares of Franklin Resources, Inc. (NYSE:BEN) by 14.0% in the second quarter, HoldingsChannel reports. The firm owned 47,741 shares of the closed-end fund’s stock after selling 7,802 shares during the period. NN Investment Partners Holdings N.V.’s holdings in Franklin Resources were worth $1,530,000 at the end of the most recent reporting period.

Top 10 Heal Care Stocks To Invest In Right Now: Heritage Financial Corporation(HFWA)

Advisors’ Opinion:

  • [By Shane Hupp]

    UBS Group AG lifted its position in Heritage Financial Corp (NASDAQ:HFWA) by 351.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,457 shares of the financial services provider’s stock after purchasing an additional 18,256 shares during the period. UBS Group AG owned about 0.07% of Heritage Financial worth $717,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Max Byerly]

    PCSB Bank (NASDAQ: PCSB) and Heritage Financial (NASDAQ:HFWA) are both small-cap finance companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings and institutional ownership.

  • [By Stephan Byrd]

    Southern Missouri Bancorp (NASDAQ: SMBC) and Heritage Financial (NASDAQ:HFWA) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Top 10 Heal Care Stocks To Invest In Right Now: KBR, Inc.(KBR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on KBR (KBR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Kubera Coin (CURRENCY:KBR) traded up 1.2% against the dollar during the one day period ending at 11:00 AM ET on August 26th. In the last week, Kubera Coin has traded up 66.9% against the dollar. One Kubera Coin token can now be bought for $0.0027 or 0.00000041 BTC on popular cryptocurrency exchanges including HitBTC and Cryptopia. Kubera Coin has a total market capitalization of $311,598.00 and approximately $6,830.00 worth of Kubera Coin was traded on exchanges in the last day.

  • [By Stephan Byrd]

    KBR, Inc. (NYSE:KBR) announced a quarterly dividend on Friday, August 10th, Wall Street Journal reports. Investors of record on Monday, September 17th will be given a dividend of 0.08 per share by the construction company on Monday, October 15th. This represents a $0.32 annualized dividend and a dividend yield of 1.58%. The ex-dividend date is Friday, September 14th.

Best Value Stocks To Invest In Right Now

Epoch Investment Partners Inc. boosted its position in shares of Republic Services (NYSE:RSG) by 21.3% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 318,852 shares of the business services provider’s stock after acquiring an additional 55,925 shares during the period. Epoch Investment Partners Inc.’s holdings in Republic Services were worth $21,118,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of RSG. SeaCrest Wealth Management LLC purchased a new stake in Republic Services during the fourth quarter valued at approximately $121,000. Signaturefd LLC purchased a new stake in Republic Services during the first quarter valued at approximately $149,000. Tower Research Capital LLC TRC lifted its position in Republic Services by 1,070.1% during the fourth quarter. Tower Research Capital LLC TRC now owns 2,937 shares of the business services provider’s stock valued at $199,000 after acquiring an additional 2,686 shares during the last quarter. Focused Wealth Management Inc purchased a new stake in Republic Services during the fourth quarter valued at approximately $199,000. Finally, Schroder Investment Management Group lifted its position in Republic Services by 41.4% during the fourth quarter. Schroder Investment Management Group now owns 3,104 shares of the business services provider’s stock valued at $210,000 after acquiring an additional 909 shares during the last quarter. 60.11% of the stock is owned by institutional investors.

Best Value Stocks To Invest In Right Now: Northgate Minerals Corporation(NXG)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of NEX Group PLC (LON:NXG) have been given an average rating of “Hold” by the nine ratings firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is GBX 696 ($9.21).

Best Value Stocks To Invest In Right Now: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion.
    Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion.
    The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion.
    Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million.
    Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion.
    LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion.
    Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion.
    TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million.
    The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million.
    A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion.
    Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million.
    Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million.
    ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million.
    KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Jazz Pharmaceuticals (JAZZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Jazz Pharmaceuticals (NASDAQ:JAZZ) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Jazz Pharmaceuticals’ sleep disorder drug, Xyrem, has witnessed improved volume trends so far in 2018, sales were  disappointing in 2017. Notably, Xyrem generates majority of sales, and consequently any setback is likely to hamper Jazz’s top-line. Moreover, Jazz has been facing supply crunch for its leukemia drug, Erwinaze, owing to constrained manufacturing capacity. These supply challenges are expected to continue in 2019. Meanwhile, its newest drug Vyxeos performed below expectations leading Jazz to lower its full-year outlook. However, management seems confident that Xyrem will continue to generate volume growth in future quarters. The company’s lead pipeline candidate solriamfetol complements its existing sleep disorder portfolio. Estimates movement remianed mixed ahead of Q4 earnings. Jazz has a positive record of earnings surprises in the recent quarters.”

  • [By Max Byerly]

    Jazz Pharmaceuticals (NASDAQ:JAZZ) was downgraded by equities research analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued on Friday.

  • [By Logan Wallace]

    Swiss National Bank trimmed its holdings in shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) by 13.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 192,000 shares of the specialty pharmaceutical company’s stock after selling 29,100 shares during the quarter. Swiss National Bank owned 0.32% of Jazz Pharmaceuticals worth $28,990,000 at the end of the most recent reporting period.

  • [By Brian Feroldi, Keith Speights, and Sean Williams]

    So which biotechnology stocks do we think are smart buys right now? We asked these three Motley Fool investors — all healthcare experts — to weigh in, and they picked Vertex Pharmaceuticals (NASDAQ:VRTX), Jazz Pharmaceuticals (NASDAQ:JAZZ), and Neurocrine Biosciences (NASDAQ:NBIX).

Best Value Stocks To Invest In Right Now: RMG Networks Holding Corporation(RMGN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Media coverage about RMG Networks (NASDAQ:RMGN) has trended somewhat positive on Sunday, according to Accern. The research firm ranks the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. RMG Networks earned a news sentiment score of 0.08 on Accern’s scale. Accern also assigned news articles about the business services provider an impact score of 45.2069122997124 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Best Value Stocks To Invest In Right Now: Vermillion, Inc.(VRML)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Media headlines about Vermillion (NASDAQ:VRML) have been trending somewhat positive this week, Accern reports. The research firm ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Vermillion earned a coverage optimism score of 0.03 on Accern’s scale. Accern also gave media headlines about the company an impact score of 46.6924212135165 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Joseph Griffin]

    Vermillion (NASDAQ: VRML) and Myriad Genetics (NASDAQ:MYGN) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership.

  • [By Benzinga News Desk]

    Shari Redstone is one “disloyal” media heiress, according to CBS (NYSE: CBS): Link

    ECONOMIC DATA
    US Initial Jobless Claims for May 18 234.0K vs 220.0K Est; Prior 222.0K. US Continuing Claims for May 11 1.74M vs 1.75M Est; Prior 1.71M
    Existing home sales report for April will be released at 10:00 a.m. ET.
    The Energy Information Administration’s weekly report on natural gas stocks in underground storage is schedule for release at 10:30 a.m. ET.
    Atlanta Fed President Raphael Bostic will speak at 10:35 a.m. ET.
    The Treasury is set to auction 7-year notes at 1:00 p.m. ET.
    The Kansas City Fed manufacturing index for May will be released at 11:00 a.m. ET.
    Philadelphia Federal Reserve Bank President Patrick Harker is set to speak at 2:00 p.m. ET.
    Data on money supply for the latest week will be released at 4:30 p.m. ET.
    ANALYST RATINGS
    UBS upgrades Deere (NYSE: DE) from Neutral to Buy
    Wells Fargo upgrades Oceaneering (NYSE: OII) from Market Perform to Outperform
    Canaccord downgrades Vermillion (NASDAQ: VRML) from Buy to Hold
    Wedbush downgrades Karyopharm Therapeutics (NASDAQ: KPTI) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

Best Value Stocks To Invest In Right Now: EMCORE Corporation(EMKR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    EMCORE Co. (NASDAQ:EMKR) traded up 8% during mid-day trading on Monday . The stock traded as high as $5.10 and last traded at $5.26. 11,341 shares changed hands during trading, a decline of 95% from the average session volume of 216,974 shares. The stock had previously closed at $4.87.

  • [By Stephan Byrd]

    EMCORE Co. (NASDAQ:EMKR) has been assigned a consensus rating of “Hold” from the six ratings firms that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and two have given a buy recommendation to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $6.00.

  • [By Max Byerly]

    News stories about EMCORE (NASDAQ:EMKR) have been trending somewhat positive this week, according to Accern Sentiment. The research group identifies positive and negative media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. EMCORE earned a news sentiment score of 0.10 on Accern’s scale. Accern also gave media stories about the semiconductor company an impact score of 45.6118508960632 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

  • [By Logan Wallace]

    News articles about EMCORE (NASDAQ:EMKR) have been trending somewhat positive this week, Accern Sentiment reports. The research firm identifies negative and positive news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. EMCORE earned a media sentiment score of 0.07 on Accern’s scale. Accern also gave media coverage about the semiconductor company an impact score of 46.9972095148836 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

  • [By Peter Graham]

    Small cap fiber-optic networking product Applied Optoelectronics (NASDAQ: AAOI), a potential peer of EMCORE Corporation (NASDAQ: EMKR), Finisar Corporation (NASDAQ: FNSR) and Oclaro Inc (NASDAQ: OCLR), is the most shorted stock on the NASDAQ with short interest of 62.65% according to Highshortnterest.com.

Best Value Stocks To Invest In Right Now: Ecolab Inc.(ECL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Ecolab Inc. (NYSE:ECL) – Jefferies Financial Group dropped their Q4 2018 EPS estimates for Ecolab in a report released on Tuesday, July 31st. Jefferies Financial Group analyst L. Alexander now anticipates that the basic materials company will post earnings per share of $1.73 for the quarter, down from their prior forecast of $1.74.

  • [By Scott Levine]

    Here are three starkly different opportunities — Aqua America (NYSE:WTR), Franco-Nevada Corp. (NYSE:FNV), and Ecolab (NYSE:ECL) — that could help investors avoid tossing and turning all night.

  • [By Max Byerly]

    In other news, Chairman Douglas M. Baker, Jr. sold 40,025 shares of the stock in a transaction on Wednesday, November 7th. The shares were sold at an average price of $160.20, for a total transaction of $6,412,005.00. Following the completion of the sale, the chairman now directly owns 558,017 shares in the company, valued at $89,394,323.40. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Leslie S. Biller sold 2,811 shares of the stock in a transaction on Friday, November 30th. The stock was sold at an average price of $160.40, for a total transaction of $450,884.40. Following the sale, the director now owns 57,842 shares of the company’s stock, valued at $9,277,856.80. The disclosure for this sale can be found here. Corporate insiders own 1.50% of the company’s stock.

    ILLEGAL ACTIVITY NOTICE: “Ecolab (ECL) Updates Q4 Earnings Guidance” was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another website, it was stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this story can be read at www.tickerreport.com/banking-finance/4125845/ecolab-ecl-updates-q4-earnings-guidance.html.

    About Ecolab

Top 5 Value Stocks To Buy For 2019

After Coca-Cola (NYSE:KO) reported its second-quarter results late last month, senior leadership shared some important details of the progress its making on several fronts during its investor call.

Here are the biggest takeaways for long-term shareholders.

Diet Coke’s new flavors are a big hit. Image source: Coca-Cola.

Share gains

Let me start by saying and underlining that we’re winning in a dynamic and vibrant industry. The global beverage industry is growing faster than last year, driven by better results in the emerging and developing markets, and also the sparkling soft drink category. We’re gaining value share as we execute on the strategies we laid out for you in early 2017, and importantly, our operating performance is accelerating as a result. — CEO James Quincey

Top 5 Value Stocks To Buy For 2019: Simulations Plus, Inc.(SLP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Simulations Plus, Inc. (NASDAQ:SLP) Director Walter S. Woltosz sold 18,500 shares of the business’s stock in a transaction dated Thursday, September 27th. The shares were sold at an average price of $19.92, for a total value of $368,520.00. Following the completion of the transaction, the director now directly owns 5,417,908 shares of the company’s stock, valued at $107,924,727.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

  • [By Stephan Byrd]

    Mattersight (NASDAQ: MATR) and Simulations Plus (NASDAQ:SLP) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings and analyst recommendations.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Simulations Plus (SLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Simulations Plus (NASDAQ: SLP) and NetScout Systems (NASDAQ:NTCT) are both computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations.

  • [By Shane Hupp]

    News headlines about Simulations Plus (NASDAQ:SLP) have trended somewhat positive on Tuesday, Accern reports. The research firm rates the sentiment of media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Simulations Plus earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned media headlines about the technology company an impact score of 45.8174942937785 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

  • [By Stephan Byrd]

    Simulations Plus (NASDAQ:SLP) and CSRA (NYSE:CSRA) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, earnings, institutional ownership, risk and valuation.

Top 5 Value Stocks To Buy For 2019: Tiptree Financial Inc.(TIPT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Tiptree Inc (NASDAQ:TIPT) CFO Sandra Bell sold 8,682 shares of the business’s stock in a transaction on Monday, September 17th. The shares were sold at an average price of $6.55, for a total transaction of $56,867.10. Following the completion of the sale, the chief financial officer now directly owns 41,881 shares of the company’s stock, valued at $274,320.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

  • [By Tim Melvin]

    This week, I ran across Tiptree Inc. (Nasdaq: TIPT) on the list of stocks with the highest VQScores. Tiptree fits most of my parameters as well so I spent a little time digging into the company further.

  • [By Joseph Griffin]

    TRADEMARK VIOLATION WARNING: “Tiptree (TIPT) Raised to C at TheStreet” was posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this piece of content can be accessed at www.tickerreport.com/banking-finance/3350618/tiptree-tipt-raised-to-c-at-thestreet.html.

Top 5 Value Stocks To Buy For 2019: Era Group, Inc.(ERA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Co-Diagnostics, Inc. (NASDAQ: CODX) fell 11.6 percent to $3.13 in pre-market trading after surging 118.52 percent on Tuesday.
    Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) shares fell 6.5 percent to $2.60 in pre-market trading after rising 1.09 percent on Tuesday.
    T2 Biosystems, Inc. (NASDAQ: TTOO) fell 6 percent to $7.58 in pre-market trading after dropping 9.13 percent on Tuesday.
    Era Group Inc. (NYSE: ERA) fell 4.8 percent to $12.30 in the pre-market trading session.
    DSW Inc. (NYSE: DSW) shares fell 4.1 percent to $25.00 in pre-market trading after reporting Q1 results.
    ZTO Express (Cayman) Inc. (NYSE: ZTO) shares fell 2.7 percent to $20.25 in pre-market trading after rising 7.88 percent on Tuesday.
    Daktronics, Inc. (NASDAQ: DAKT) fell 2.5 percent to $9.81 in pre-market trading. Daktronics is expected to release quarterly earnings today.
    AngloGold Ashanti Limited (NYSE: AU) fell 2.2 percent to $8.28 in pre-market trading

  • [By Logan Wallace]

    Media stories about Era Group (NYSE:ERA) have been trending somewhat positive recently, Accern reports. Accern ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Era Group earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned headlines about the transportation company an impact score of 47.38255838638 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

  • [By Logan Wallace]

    ERA (CURRENCY:ERA) traded down 12.1% against the US dollar during the 1 day period ending at 22:00 PM ET on June 30th. One ERA coin can currently be purchased for about $0.0073 or 0.00000115 BTC on popular exchanges including CoinExchange and Cryptohub. Over the last week, ERA has traded 1.6% lower against the US dollar. ERA has a market capitalization of $0.00 and approximately $299.00 worth of ERA was traded on exchanges in the last day.

  • [By Logan Wallace]

    Era Group (NYSE:ERA) was upgraded by research analysts at ValuEngine from a “hold” rating to a “buy” rating in a report released on Saturday.

Top 5 Value Stocks To Buy For 2019: Flagstar Bancorp, Inc.(FBC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Millennium Management LLC lessened its position in shares of Flagstar Bancorp Inc (NYSE:FBC) by 87.9% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 6,422 shares of the savings and loans company’s stock after selling 46,458 shares during the quarter. Millennium Management LLC’s holdings in Flagstar Bancorp were worth $227,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Flagstar Bancorp (FBC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Jordan Wathen]

    In a win-win deal, deposit-starved Flagstar Bancorp (NYSE:FBC) will take Wells Fargo’s underperforming branches off of its hands — and pay a premium to do it. 

  • [By Joseph Griffin]

    EJF Capital LLC lowered its stake in shares of Flagstar Bancorp Inc (NYSE:FBC) by 14.1% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,056,997 shares of the savings and loans company’s stock after selling 173,003 shares during the quarter. Flagstar Bancorp makes up approximately 3.0% of EJF Capital LLC’s holdings, making the stock its 8th biggest holding. EJF Capital LLC’s holdings in Flagstar Bancorp were worth $37,418,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Stephens reiterated their hold rating on shares of Flagstar Bancorp (NYSE:FBC) in a research report sent to investors on Monday morning.

    Several other brokerages have also weighed in on FBC. B. Riley reissued a buy rating on shares of Flagstar Bancorp in a report on Friday, March 2nd. Sandler O’Neill raised Flagstar Bancorp from a hold rating to a buy rating in a report on Thursday, June 7th. Boenning Scattergood reissued a buy rating and issued a $41.00 price objective on shares of Flagstar Bancorp in a report on Wednesday, June 6th. Zacks Investment Research lowered Flagstar Bancorp from a strong-buy rating to a hold rating in a report on Tuesday, February 13th. Finally, Wedbush decreased their price objective on Flagstar Bancorp from $45.00 to $40.00 and set an outperform rating for the company in a report on Thursday, April 12th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the stock. The company currently has a consensus rating of Buy and an average price target of $40.43.

Top 5 Value Stocks To Buy For 2019: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Jazz Pharmaceuticals (JAZZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Keybank National Association OH purchased a new position in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 2,808 shares of the specialty pharmaceutical company’s stock, valued at approximately $484,000.

  • [By Logan Wallace]

    Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)’s share price hit a new 52-week high and low during mid-day trading on Tuesday . The company traded as low as $173.93 and last traded at $172.72, with a volume of 22282 shares. The stock had previously closed at $172.50.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Jazz Pharmaceuticals (JAZZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Own Right Now

LISTEN TO ARTICLE 3:18 SHARE THIS ARTICLE Facebook Twitter LinkedIn Email

BOE Technology Group Co.’s stock market reversal is dramatic even by China’s outsized standards. It took less than a year for the Apple Inc. supplier to go from one of the nation’s best-performing stocks to among its worst — a precipitous selloff that may not be over.

China’s largest maker of screens for TVs and phones shed more than 32 percent of its value this year, the steepest decline among the 50 biggest companies listed in Shanghai and Shenzhen. That was prompted by ballooning supply and plunging prices for the large screens that comprise most of its business. Even earning a coveted spot on Apple’s list of top 200 suppliers couldn’t overcome fears that demand-supply imbalances will persist, analysts say.

Top 10 Performing Stocks To Own Right Now: Interactive Brokers Group, Inc.(IBKR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Interactive Brokers Group (NASDAQ:IBKR) had its price target cut by SunTrust Banks to $71.00 in a research report sent to investors on Wednesday. They currently have a $65.34 rating on the financial services provider’s stock. SunTrust Banks also issued estimates for Interactive Brokers Group’s Q3 2018 earnings at $0.54 EPS, Q4 2018 earnings at $0.59 EPS, FY2018 earnings at $2.34 EPS, Q1 2019 earnings at $0.60 EPS, Q2 2019 earnings at $0.64 EPS, Q3 2019 earnings at $0.66 EPS, Q4 2019 earnings at $0.70 EPS and FY2019 earnings at $2.60 EPS.

  • [By Stephan Byrd]

    Interactive Brokers Group (NASDAQ: IBKR) and Charles Schwab Co. Common Stock (NYSE:SCHW) are both large-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, earnings, analyst recommendations, profitability and risk.

  • [By Joseph Griffin]

    Here are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:

    Get Interactive Brokers Group alerts:

    What Could Attract Investors to Interactive Brokers (finance.yahoo.com) Reviewing Charles Schwab (SCHW) and Interactive Brokers Group (IBKR) (americanbankingnews.com) Interactive Brokers Group (IBKR) Presents At Sandler O’Neill’s Global Exchange And Brokerage Conference – Slideshow (seekingalpha.com) Should You Invest In The Financial Stock Interactive Brokers Group Inc (NASDAQ:IBKR)? (finance.yahoo.com) Interactive Brokers Welcomes New Bond Disclosure Rules (finance.yahoo.com)

    Shares of Interactive Brokers Group traded up $1.20, reaching $71.38, during midday trading on Friday, according to MarketBeat Ratings. 1,131,168 shares of the company were exchanged, compared to its average volume of 859,815. The stock has a market cap of $29.39 billion, a PE ratio of 46.65, a PEG ratio of 1.65 and a beta of 0.95. Interactive Brokers Group has a one year low of $36.23 and a one year high of $80.32.

  • [By Dustin Blitchok]

    The European Union’s General Data Protection Regulation takes effect May 25, and Steve Sanders, the executive vice president of marketing and product development at Interactive Brokers (NASDAQ: IBKR), described it as the “bane of my existence.” Compliance with the regulations is taking resources from other products at the online brokerage, he said.

  • [By Max Byerly]

    Compass Point started coverage on shares of Interactive Brokers Group (NASDAQ:IBKR) in a research note published on Tuesday. The brokerage issued a neutral rating and a $74.00 price target on the financial services provider’s stock.

Top 10 Performing Stocks To Own Right Now: Park-Ohio Holdings Corp.(PKOH)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Park-Ohio (PKOH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Park-Ohio (PKOH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Park-Ohio (NASDAQ: PKOH) and Materion (NYSE:MTRN) are both small-cap industrial products companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, dividends, risk, analyst recommendations, earnings and valuation.

  • [By Logan Wallace]

    Park-Ohio (NASDAQ: PKOH) and Shiloh Industries (NASDAQ:SHLO) are both small-cap industrial products companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

Top 10 Performing Stocks To Own Right Now: Monotype Imaging Holdings Inc.(TYPE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Here are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:

    Get Monotype Imaging alerts:

    Should You Be Holding Monotype Imaging Holdings Inc (NASDAQ:TYPE)? (finance.yahoo.com) Monotype Imaging Holdings Inc. (TYPE) Forecasted to Earn Q1 2019 Earnings of $0.07 Per Share (americanbankingnews.com) Monotype Partners with PKU Founder Information Industry Group to Bring Latin Typefaces to Enterprise Brands and Creative Professionals in China (finance.yahoo.com) $59.42 Million in Sales Expected for Monotype Imaging Holdings Inc. (TYPE) This Quarter (americanbankingnews.com) Introducing the Walbaum Typeface: the Restoration of a Warm and Stylish Serif Design That Has Nearly Limitless Applications (finance.yahoo.com)

    TYPE has been the topic of a number of research analyst reports. B. Riley raised shares of Monotype Imaging from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $24.50 to $31.00 in a research report on Tuesday, February 20th. Zacks Investment Research raised shares of Monotype Imaging from a “hold” rating to a “buy” rating and set a $27.00 price objective on the stock in a research report on Tuesday, February 27th. ValuEngine raised shares of Monotype Imaging from a “sell” rating to a “hold” rating in a research report on Tuesday, February 20th. TheStreet downgraded shares of Monotype Imaging from a “b” rating to a “c+” rating in a research report on Friday, April 27th. Finally, BidaskClub downgraded shares of Monotype Imaging from a “hold” rating to a “sell” rating in a research report on Saturday, May 12th. Two analysts have rated the stock with a sell rating, one has given a hold rating and two have issued a buy rating to the stock. Monotype Imaging presently has an average rating of “Hold” and an average p

  • [By Joseph Griffin]

    Monotype Imaging (NASDAQ:TYPE) was downgraded by stock analysts at BidaskClub from a “hold” rating to a “sell” rating in a note issued to investors on Saturday.

  • [By Max Byerly]

    Zscaler (NASDAQ: ZS) and Monotype Imaging (NASDAQ:TYPE) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, dividends, earnings, institutional ownership and risk.

  • [By Joseph Griffin]

    BidaskClub upgraded shares of Monotype Imaging (NASDAQ:TYPE) from a sell rating to a hold rating in a research report report published on Tuesday morning.

Top 10 Performing Stocks To Own Right Now: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Keith Speights]

    But at least three of the biotechs singled out by the FDA deserve to be on another list — investors’ buy lists. Here’s why Celgene (NASDAQ:CELG), Gilead Sciences (NASDAQ:GILD), and Jazz Pharmaceuticals (NASDAQ:JAZZ) look like great stock picks right now.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Jazz Pharmaceuticals (JAZZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Private Capital Advisors Inc. acquired a new position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) during the second quarter, HoldingsChannel reports. The institutional investor acquired 24,200 shares of the specialty pharmaceutical company’s stock, valued at approximately $4,170,000.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Jazz Pharmaceuticals (JAZZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Here are some of the news headlines that may have impacted Accern’s rankings:

    Get Jazz Pharmaceuticals alerts:

    Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data from Phase 3 TONES 5 Study of Solriamfetol for Excessive Sle… (advfn.com) Jazz Pharmaceuticals (JAZZ) Given a $194.00 Price Target at Royal Bank of Canada (americanbankingnews.com) Analyzing Jazz Pharmaceuticals (JAZZ) & Celyad (CYAD) (americanbankingnews.com) Global Marine Pharmaceuticals Market Growing at a CAGR of 7.28% to 2022 (empowerednews.net) Physicians Unaware of Neurologic Effects Related to Obstructive Sleep Apnea, Finds Jazz Pharmaceuticals Survey (sleepreviewmag.com)

    Shares of Jazz Pharmaceuticals traded up $1.75, hitting $170.75, during trading on Friday, MarketBeat reports. 928,650 shares of the company were exchanged, compared to its average volume of 466,308. The firm has a market capitalization of $10.11 billion, a price-to-earnings ratio of 17.86, a price-to-earnings-growth ratio of 0.87 and a beta of 0.97. Jazz Pharmaceuticals has a fifty-two week low of $128.58 and a fifty-two week high of $171.76. The company has a quick ratio of 2.88, a current ratio of 3.00 and a debt-to-equity ratio of 0.55.

Top 10 Performing Stocks To Own Right Now: Videocon d2h Limited(VDTH)

Advisors’ Opinion:

  • [By Logan Wallace]

    Videocon d2h (NASDAQ: VDTH) and MSG Networks (NYSE:MSGN) are both small-cap consumer discretionary companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings and institutional ownership.

  • [By Joseph Griffin]

    Videocon d2h (NASDAQ: VDTH) and DISCOVERY COMMUNICATIONS INC. Common Stock (NASDAQ:DISCA) are both consumer discretionary companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings.

Top 10 Performing Stocks To Own Right Now: Murphy Oil Corporation(MUR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Clinton Group Inc. purchased a new stake in Murphy Oil Co. (NYSE:MUR) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 14,491 shares of the oil and gas producer’s stock, valued at approximately $489,000.

  • [By Stephan Byrd]

    Murphy Oil Co. (NYSE:MUR) has earned an average rating of “Hold” from the twelve analysts that are presently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation, two have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $31.56.

Top 10 Performing Stocks To Own Right Now: Gold Standard Ventures Corporation(GSV)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Gold Standard Ventures Corp (NYSEAMERICAN:GSV) was the recipient of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 6,511,796 shares, a drop of 7.7% from the April 30th total of 7,056,069 shares. Based on an average daily volume of 268,131 shares, the short-interest ratio is currently 24.3 days. Approximately 5.9% of the company’s stock are sold short.

Top 10 Performing Stocks To Own Right Now: GRAVITY Co. Ltd.(GRVY)

Advisors’ Opinion:

  • [By Cooper Creagan]

    For example, if you had taken five minutes to set up a Night Trade on Gravity Co. (Nasdaq: GRVY) in October, you could’ve tripled your money, and then some.

  • [By Max Byerly]

    ILLEGAL ACTIVITY WARNING: “Gravity (GRVY) Receives Coverage Optimism Score of 0.17” was first published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another publication, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be viewed at www.tickerreport.com/banking-finance/3382037/gravity-grvy-receives-coverage-optimism-score-of-0-17.html.

  • [By Joseph Griffin]

    BidaskClub upgraded shares of Gravity (NASDAQ:GRVY) from a strong sell rating to a sell rating in a research note issued to investors on Tuesday morning.

Top 10 Performing Stocks To Own Right Now: Sarepta Therapeutics, Inc.(SRPT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Sarepta Therapeutics (NASDAQ:SRPT)’s share price reached a new 52-week high and low on Wednesday after Leerink Swann raised their price target on the stock from $88.00 to $121.00. Leerink Swann currently has an outperform rating on the stock. Sarepta Therapeutics traded as low as $95.67 and last traded at $94.81, with a volume of 42782 shares trading hands. The stock had previously closed at $92.22.

  • [By Stephan Byrd]

    Trexquant Investment LP acquired a new position in Sarepta Therapeutics (NASDAQ:SRPT) in the first quarter, Holdings Channel reports. The institutional investor acquired 7,135 shares of the biotechnology company’s stock, valued at approximately $529,000.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Sarepta Therapeutics (SRPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Keith Speights]

    Three biotech stocks — Solid Biosciences (NASDAQ:SLDB), Sarepta Therapeutics (NASDAQ:SRPT), and Heron Therapeutics (NASDAQ:HRTX) — soared this week by 30% or more thanks to news that brought smiles to investors’ faces. Here’s what drove these stocks higher and whether or not they’resmart picks to buy now.

  • [By Chris Lange]

    Sarepta Therapeutics Inc. (NASDAQ: SRPT) shares skyrocketed on Tuesday after the firm presented positive preliminary results from its midstage Duchenne muscular dystrophy (DMD) trial. Specifically, the results came from Sareptas Phase 1/2a gene therapy clinical trial assessing AAVrh74.MHCK7.micro-Dystrophin in individuals with DMD.

  • [By Logan Wallace]

    Barclays upgraded shares of Sarepta Therapeutics (NASDAQ:SRPT) from an equal weight rating to an overweight rating in a research report released on Friday morning, MarketBeat.com reports. They currently have $107.00 target price on the biotechnology company’s stock, up from their prior target price of $55.00.

Top 10 Performing Stocks To Own Right Now: Saul Centers, Inc.(BFS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Teachers Insurance & Annuity Association of America purchased a new position in shares of Saul Centers, Inc. (NYSE:BFS) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 13,437 shares of the real estate investment trust’s stock, valued at approximately $685,000. Teachers Insurance & Annuity Association of America owned approximately 0.06% of Saul Centers at the end of the most recent quarter.

  • [By Logan Wallace]

    Shares of Saul Centers, Inc. (NYSE:BFS) have been assigned a consensus recommendation of “Hold” from the seven analysts that are presently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, four have given a hold recommendation and one has given a buy recommendation to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $54.50.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Saul Centers (BFS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Saul Centers (BFS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Value Stocks To Invest In 2019

Cornercap Investment Counsel Inc. acquired a new stake in Campbell Soup (NYSE:CPB) during the 1st quarter, HoldingsChannel.com reports. The fund acquired 63,350 shares of the company’s stock, valued at approximately $2,744,000.

A number of other large investors have also added to or reduced their stakes in the stock. Bank of New York Mellon Corp boosted its stake in Campbell Soup by 0.3% in the fourth quarter. Bank of New York Mellon Corp now owns 6,513,912 shares of the company’s stock valued at $313,384,000 after buying an additional 20,720 shares in the last quarter. Schroder Investment Management Group boosted its stake in Campbell Soup by 29.7% in the fourth quarter. Schroder Investment Management Group now owns 4,619,380 shares of the company’s stock valued at $222,238,000 after buying an additional 1,058,752 shares in the last quarter. Geode Capital Management LLC boosted its stake in Campbell Soup by 2.8% in the fourth quarter. Geode Capital Management LLC now owns 2,520,032 shares of the company’s stock valued at $121,039,000 after buying an additional 67,987 shares in the last quarter. Champlain Investment Partners LLC acquired a new stake in Campbell Soup in the first quarter valued at about $56,667,000. Finally, Guggenheim Capital LLC boosted its stake in Campbell Soup by 23.7% in the fourth quarter. Guggenheim Capital LLC now owns 1,206,442 shares of the company’s stock valued at $58,042,000 after buying an additional 231,178 shares in the last quarter. 48.66% of the stock is currently owned by institutional investors and hedge funds.

Hot Value Stocks To Invest In 2019: Century Aluminum Company(CENX)

Advisors’ Opinion:

  • [By Alexander Bird]

    Aluminum producer Century Aluminum Co. (Nasdaq: CENX) added 3.3%to its share price, and Alcoa Corp. (NYSE: AA) edged up 0.2%, both closing out the day with gains.

  • [By D.R. Barton, Jr.]

    According to industry leaders, including Century Aluminum Co. (Nasdaq: CENX) CEO Michael Bless, many of those jobs will be in jeopardy with the new taxes. And then there’s the reciprocal tariff reactions from other nations that would definitely hit the billions of dollars’ worth of U.S. agricultural exports with further jobs in jeopardy.

  • [By Jon C. Ogg]

    Century Aluminum Co. (NASDAQ: CENX) was last seen up 16 cents at $14.97, but its 52-week range is $12.94 to $24.77. Its shares have a consensus analyst target of $22.80, and this traded at nearly $18 at the start of June.

  • [By Rich Smith]

    Shares of Century Aluminum (NASDAQ:CENX)are off 9.7% as of 11 a.m. EDT despite the company reporting a sizable earnings “beat” this morning. Instead of posting expected pro forma losses of $0.23 per share for its fiscal first-quarter 2018, its loss for the quarter was less than $0.01 per share ($0.04 after adjusting for one-time items).

  • [By Matthew DiLallo]

    Shares of aluminum producers Century Aluminum Co. (NASDAQ:CENX) and Alcoa Corp. (NYSE:AA) tumbled on Thursday, falling more than 10% and 13%, respectively, by 2:30 p.m. EDT. Driving the decline was Alcoa’s second-quarter earnings report, which detailed a “significant” impact from aluminum tariffs instituted this year.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Check-Cap Ltd. (NASDAQ: CHEK) shares dipped 47.8 percent to $4.60. Check-Cap priced its upsized underwritten offering of public units at $5.50 per unit.
    VivoPower International PLC (NASDAQ: VVPR) shares fell 41.5 percent to $2.57.
    Universal Electronics Inc. (NASDAQ: UEIC) dropped 35.1 percent to $29.50 after the company posted downbeat quarterly results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) dropped 34.8 percent to $3.75 after climbing 155.56 percent on Thursday.
    Integrated Media Technology Limited (NASDAQ: IMTE) fell 25.2 percent to $24.01 after surging 46.29 percent on Thursday.
    Fluor Corporation (NYSE: FLR) dropped 22.5 percent to $45.73 after the company reported downbeat earnings for its first quarter and lowered its profit outlook for the year.
    AMN Healthcare Services, Inc (NYSE: AMN) shares fell 19.6 percent to $52.075 following Q1 earnings.
    Adverum Biotechnologies, Inc. (NASDAQ: ADVM) shares declined 18.1 percent to $5.20. Adverum Biotech disclosed that its CEO Amber Salzman is stepping down.
    Newater Technology, Inc. (NASDAQ: NEWA) dropped 17.2 percent to $12.83.
    Basic Energy Services, Inc. (NYSE: BAS) fell 17.2 percent to $13.65 following Q1 results.
    Xperi Corporation (NASDAQ: XPER) declined 15.8 percent to $19.40 after announcing Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares fell 15.1 percent to $3.649 after climbing 22.16 percent on Thursday.
    Performant Financial Corporation (NASDAQ: PFMT) dropped 14.2 percent to $2.65.
    Gogo Inc. (NASDAQ: GOGO) shares fell 13.2 percent to $8.32 after the company reported Q1 results and disclosed that it is withdrawing its FY18 outlook for adjusted EBITDA, airborne cash capex, airborne equipment inventory purchases and free cash flow.
    Technical Communications Corporation (NASDAQ: TCCO) dropped 12.2 percent to $5.05.
    Web.com Group, Inc. (NASDAQ: WEB) fell 9.7 percent

Hot Value Stocks To Invest In 2019: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Max Byerly]

    Here are some of the news headlines that may have impacted Accern’s rankings:

    Get Jazz Pharmaceuticals alerts:

    Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data from Phase 3 TONES 5 Study of Solriamfetol for Excessive Sle… (advfn.com) Jazz Pharmaceuticals (JAZZ) Given a $194.00 Price Target at Royal Bank of Canada (americanbankingnews.com) Analyzing Jazz Pharmaceuticals (JAZZ) & Celyad (CYAD) (americanbankingnews.com) Global Marine Pharmaceuticals Market Growing at a CAGR of 7.28% to 2022 (empowerednews.net) Physicians Unaware of Neurologic Effects Related to Obstructive Sleep Apnea, Finds Jazz Pharmaceuticals Survey (sleepreviewmag.com)

    Shares of Jazz Pharmaceuticals traded up $1.75, hitting $170.75, during trading on Friday, MarketBeat reports. 928,650 shares of the company were exchanged, compared to its average volume of 466,308. The firm has a market capitalization of $10.11 billion, a price-to-earnings ratio of 17.86, a price-to-earnings-growth ratio of 0.87 and a beta of 0.97. Jazz Pharmaceuticals has a fifty-two week low of $128.58 and a fifty-two week high of $171.76. The company has a quick ratio of 2.88, a current ratio of 3.00 and a debt-to-equity ratio of 0.55.

  • [By Shane Hupp]

    Private Capital Advisors Inc. acquired a new position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) during the second quarter, HoldingsChannel reports. The institutional investor acquired 24,200 shares of the specialty pharmaceutical company’s stock, valued at approximately $4,170,000.

  • [By Keith Speights]

    But at least three of the biotechs singled out by the FDA deserve to be on another list — investors’ buy lists. Here’s why Celgene (NASDAQ:CELG), Gilead Sciences (NASDAQ:GILD), and Jazz Pharmaceuticals (NASDAQ:JAZZ) look like great stock picks right now.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion.
    Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion.
    The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion.
    Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million.
    Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion.
    LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion.
    Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion.
    TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million.
    The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million.
    A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion.
    Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million.
    Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million.
    ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million.
    KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Jazz Pharmaceuticals (JAZZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Value Stocks To Invest In 2019: Regis Corporation(RGS)

Advisors’ Opinion:

  • [By Max Byerly]

    JPMorgan Chase & Co. reduced its position in shares of Regis Co. (NYSE:RGS) by 4.0% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,065,983 shares of the company’s stock after selling 44,497 shares during the quarter. JPMorgan Chase & Co. owned about 2.31% of Regis worth $16,128,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Shares of Regis Co. (NYSE:RGS) have been given an average rating of “Buy” by the six ratings firms that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $18.00.

  • [By Stephan Byrd]

    Regis Co. (NYSE:RGS) reached a new 52-week high and low during trading on Wednesday . The stock traded as low as $17.50 and last traded at $17.50, with a volume of 3726 shares changing hands. The stock had previously closed at $17.43.

Hot Value Stocks To Own Right Now

Medidata’s architecture, reporting and analytics – a straightforward growth strategy

Most investors including myself are constantly looking at screens for new ideas. It may be that there have been fewer IPOs lately than the historical norm, but that does not mean that there aren’t plenty of IT names, far beyond the abilities of my brain to encompass, that are worth a look.

A very useful tool for screening that I have found recently comes from the team that covers the IT space at Credit Suisse (NYSE:CS). CS has a team that exclusively covers SaaS software vendors. The team has developed a tool based on linear regression that portrays a method of valuing the companies in their universe. The results of their work is a graphic that plots what they describe as the unit economics of 37 different vendors who sell their software on a subscription basis. The graphic illustrates a plot of the unit economics, i.e. the customer lifetime value/customer acquisition costs as defined by the analysts against their EV/S ratios as forecast for the next 12 months. It sounds far more complicated than is really the case. I like the tool developed by the analysts as providing some kind of reality check in terms of looking at a wide variety of software vendors addressing different markets. It is a tool that relates to both growth and efficiency, one of the most difficult analytical conundrums with which to deal. It replaces the conventions of accounting that do not properly account for the economics of the new software world and which lead many observers and commentators into a land of pointless nay saying that leads to conclusions that ultimately do not work out.

Hot Value Stocks To Own Right Now: SteadyMed Ltd.(STDY)

Advisors’ Opinion:

  • [By Lisa Levin]

    Gainers

    Pyxis Tankers Inc. (NYSE: PXS) rose 47.48 percent to $$5.56, after the company announced it has entered into a definitive securities purchase agreement with a group of investors, which will result in gross proceeds of $4.8 million.
    Sigma Designs Inc (NASDAQ: SIGM) rose 22.77 percent to $6.88. Silicon Laboratories (NASDAQ: SLAB) announced plans to buy Sigma Designs for $7.05 per share in cash.
    Steadymed Ltd (NASDAQ: STDY) rose 19.35 percent to $3.70, after the company reported that no clinical trials were required for Trevyent and that the FDA had agreed to the pathway for the drug candidate's NDA resubmission.
    Iteris, Inc. (NASDAQ: ITI) rose 15.73 percent to $7.06. Earlier in the week, Zacks Investment Research had upgraded the company from "Sell" to "Hold".
    Science Applications International Corp (NYSE: SAIC) rose 13.71 percent to $85.77 as the company reported better-than-expected earnings for its third quarter.
    Technical Communications Corporation (NASDAQ: TCCO) rose 12.41 percent to $6.07, after having risen sharply in pre-marketing trading.
    Radius Health, Inc. (NASDAQ: RDUS) rose 12.41 percent to $30.81 after the company provided an update on data from the Phase 1 005 clinical study of elacestrant in patients with estrogen receptor positive breast cancer during the 2017 San Antonio Breast Cancer Symposium.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 12.32 percent to $25.80 after the company reported its third quarter financial results.
    Prana Biotechnology Limited (NASDAQ: PRAN) rose 11.36 percent to $3.43, as the company announced a research collaboration with Takeda Pharmaceuticals to study the ability of movement disorders compound, PBT434 to slow or prevent neurodegeneration of the gastrointestinal system.
    Catalyst Biosciences, Inc. (NASDAQ: CBIO) rose 10.49 percent to $7.90 as the company announced the appointment of Arwa Shurrab and Jamie Ellen Siegel in its clinical hemophilia

Hot Value Stocks To Own Right Now: Sonic Automotive Inc.(SAH)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Armour Residential REIT Inc. (NYSE: ARR), Ducommun Inc. (NYSE: DCO), PJT Partners Inc. (NYSE; PJT), Sonic Automotive Inc. (NYSE: SAH)and Tandy Leather Factory Inc. (NASDAQ: TLF).

Hot Value Stocks To Own Right Now: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Jim Robertson]

    The earnings report summarized the following recent milestones:

    The formation of a Scientific Advisory Board (SAB) to provide expert guidance and insight as the Company advances towards product commercialization. in October, Pfenex announced the hiring of Steven Sandoval as Chief Manufacturing Officer.Steven has over 25 years of commercial biopharmaceutical engineering and operations experience, specializing in commercial operations, facility design and licensure of large scale biopharmaceutical commercial manufacturing facilities. Following the announcement in August of the positive Phase 1 trial data for Pfenex’s recombinant anthrax vaccine, discussions with BARDA have been progressing. Pfenex anticipates initiating the PF708 pivotal clinical program by year end. Pfenex entered into a collaboration with Jazz Pharmaceuticals plc (NASDAQ: JAZZ) on multiple hematology/oncology product candidates in July. Regulatory feedback for PF529, Pfenex’s biosimilar candidate to Neulasta (pegfilgrastim), is expected by the end of 2016 and following that feedback, the development path and potential timeline will be outlined.

    Do you like this trading idea and want more trading setups delivered to you every day? Consider investing in a subscription to our SmallCap Network Elite Opportunity (SCN EO) portfolio newsletter or our Under the Radar Movers newsletter where you’ll get more and even better trading setups, investing ideas or tips.

  • [By Keith Speights]

    In December, I included Jazz Pharmaceuticals (NASDAQ:JAZZ) in a list of the three top healthcare stocks investors were overlooking. At that time, I noted that the biotech stock could be a diamond in the rough with its promising pipeline and low valuation.

Hot Value Stocks To Own Right Now: The Hackett Group Inc.(HCKT)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, industrial shares were relative laggards, down on the day by about 0.20 percent. Meanwhile, top losers in the sector included The Hackett Group, Inc. (NASDAQ: HCKT), down 22 percent, and PC Tel Inc (NASDAQ: PCTI), down 18 percent.

Hot Value Stocks To Own Right Now: M&T Bank Corporation(MTB)

Advisors’ Opinion:

  • [By Ben Levisohn]

    We believe investors should continue to own three types of bank stocks: “Return of Capital (RC) Stocks”, “Risk On (RO) Stocks”, and “Multiple Revaluation (MR) Stocks.” RC stocks include M&T Bank (MTB), PNC Financial Services Group (PNC), and SunTrust Banks (STI); RO stocks include Bank of America, Popular (BPOP), Citigroup, JPMorgan, and KeyCorp (KEY); and MR stocks include BB&T (BBT) and PNC Financial Services Group (PNC).

Your Daily Pharma Scoop: IRWD Division, Jazz sNDA, Siga Adcomm

Analysis focus: IRWD

Ironwood Pharma (NASDAQ:IRWD) is going to split into two separate companies, both publicly traded, with one focusing on commercialization and the other on R&D. This move will happen in the first half of 2019 and be tax free to current shareholders.

Ironwoods linzess, which was approved 6 years ago in irritable bowel syndrome with constipation and for treatment of chronic idiopathic constipation. Recently, as we know, Synergy Pharmas (NASDAQ:SGYP) Trulance got approved by the FDA for the same indications. Now, according to some sources, Trulance is a safer drug than Linzess. However, Trulance has not been able to take off as well as investors had assumed, although it has put a dent in the prospects of Linzess.

Linzess is marketed by Allergan (NYSE:AGN), which has considerable marketing prowess. Now, this bid to separate IRWD into two divisions probably owes itself to one reason – that after 6 years of approval, IRWD has still not been able to become profitable. As the announcement of this news says, the commercial division of IRWD, which is focused on Linzess, ..is expected to be profitable in 2019. That means, if you reduce the R&D expenses from the total cash burn of the company, then it could become profitable on Linzess revenues. At least, that seems to be the idea.

The other division will do R&D on cyclic guanosine monophosphate pharmacology to advance a pipeline of treatments for rare and serious diseases led by mid-stage candidates praliciguat and olinciguat. This will be the division that will look for future treatments to bring to market as Linzess completes its market cycle.

For SGYP investors, what is interesting to note here is that this move seems aimed to make Linzess profitable for at least a part of the company. That is to say, the old Ironwood has to shed the more cash burning part of it – the R&D section – to make this happen.

This could mean, either, that Trulance is really taking over some of Linzess traditional market, and/or the market itself is not sustaining enough for Linzess to make enough money to cover Ironwoods entire cash requirements, although IRWD has managed to reduce OpEx drastically.

The first idea is a good thing for Synergy investors; the second is a sobering conclusion of how just getting a product approved but without proper money and marketing management can still ruin the future prospects of a company.

In related news, IRWD released earnings results for Q1 and missed both by EPS and by revenue, despite seeing a 32% increase in revenue Y/Y.

Stocks in News: Analysis of JAZZ, SIGA

Jazz Pharma submits U.S. marketing application for expanded use of Xyrem

Discussion: Jazz Pharmas (NASDAQ:JAZZ) Xyrem was first approved in 2002 to treat cataplexy in narcolepsy and for EDS in narcolepsy. This expanded use sNDA will increase the scope of Xyrem to include pediatric patients. The market isnt much because Age of onset for narcolepsy typically occurs in the second decade of life; however, diagnosis can occur 1016 years later on average.

FDA Ad Com backs SIGA’s smallpox treatment

Discussion: Naturally occuring smallpox was eradicated in 1980, but SIGA technologies (NASDAQ:SIGA) TPOXX (tecovirimat) is an antiviral oral treatment targeting smallpox when used as a biological weapon, for which no medicine exists as of now. Vaccination is risky and not efficient for people with low exposure risks, especially for an eradicated disease. However, the market for this new drug candidate will be for defense purposes. PDUFA is August 8.

In other news

Karyopharm (NASDAQ:KPTI), which was highlighted in yesterdays scoop, has now come up with a $125mn stock offering, taking the stock down 3%.

Mallinckrodts (NYSE:MNK) stannsoporfin has an adcomm on Thursday for elevated blood bilirubin in neonates (at least 35 weeks’ gestational age) with indicators of hemolysis (rupture of red blood cells) who are at risk of developing severe hyperbilirubinemia (excess bilirubin in the blood). This is a small market.

Medtronics (NYSE:MDT) Deep Brain Stimulation therapy has been approved by the FDA as adjunctive therapy for adult patients with partial onset seizues in drug resistant epilepsy.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

SeekingAlpha

Best Bank Stocks To Watch Right Now

It’s official: Your browsing history can be sold to advertisers. President Trump on Monday signed a measure reversing rules that would have required internet providers to get consent before selling your browsing history.

The rules had not yet gone into effect, but providers now find themselves with new freedom when it comes to collecting and selling their customers’ data. What does that mean for you?

What identifying information do they have?

Internet providers already collect a lot of information that’s necessary to maintain their networks, like your location and what you’re looking at online.

Many have said they will not use “sensitive” information, like medical records, children’s data and banking details without consent. However a simple browsing history can reveal those personal details, such as symptoms you’ve Googled. There are concerns that it would be possible to identify people based on this detailed information.

According to Dane Jasper, cofounder of Sonic, an independent ISP located in California, an internet provider can infer a lot about you based just on your browsing. In addition to basics like age and gender, they might know who your friends are, if you’re a recovering alcoholic, or where you went to school. In theory, they could create an in-depth profile of you.

Best Bank Stocks To Watch Right Now: Peak Resorts, Inc.(SKIS)

Advisors’ Opinion:

  • [By Monica Gerson]

    Peak Resorts Inc (NASDAQ: SKIS) is projected to report its quarterly earnings at $0.40 per share on revenue of $42.59 million.

    BMC Stock Holdings Inc (NASDAQ: STCK) is expected to post its quarterly earnings at $0.17 per share on revenue of $449.59 million.

Best Bank Stocks To Watch Right Now: Array BioPharma Inc.(ARRY)

Advisors’ Opinion:

  • [By Lisa Levin]

    Healthcare shares gained around 0.43 percent in trading on Friday. Meanwhile, top gainers in the sector included DexCom, Inc. (NASDAQ: DXCM), and Array Biopharma Inc (NASDAQ: ARRY).

  • [By Lisa Levin] Gainers
    Loxo Oncology Inc (NASDAQ: LOXO) rose 32.7 percent to $65.00 in pre-market trading after the company reported that larotrectinib trial demonstrated 76 percent confirmed objective response rate.
    Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 22 percent to $7.20 in the pre-market trading session after the company on Friday presented updated data for SD-101 in combination with KEYTRUDA.
    Puma Biotechnology Inc (NASDAQ: PBYI) rose 21.7 percent to $99.75 in pre-market trading as the company disclosed positive PB272 Phase 2 data from TBCRC 022 trial at ASCO17.
    Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares rose 20.7 percent to $3.21 in pre-market trading after the company reported that RedZone has acquired all the assets of Trendit including three technology patents.
    Forestar Group Inc. (NYSE: FOR) rose 13.1 percent to $16.05 in pre-market trading after D.R. Horton, Inc. (NYSE: DHI) proposed to buy 75 percent of Forestar Group for $16.25 per share in cash.
    TG Therapeutics Inc (NASDAQ: TGTX) shares rose 12 percent to $15.50 in pre-market trading after the company said Phase 3 GENUINE trial met primary endpoint with TG-1101 + ibrutinib increasing overall response rate by >70 percent versuss ibrutinib alone.
    Gigamon Inc (NYSE: GIMO) gained 10.8 percent to $43.55. Reuters reported that Gigamon is exploring a potential sale.
    BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 8.7 percent to $6.00 in pre-market trading after the company announced Rapivab pediatric sNDA acceptance by the FDA.
    Array Biopharma Inc (NASDAQ: ARRY) rose 7.2 percent to $8.77 in pre-market trading after gaining 5.68 percent on Friday.
    Ehi Car Services Ltd (ADR) (NYSE: EHIC) shares rose 6.4 percent to $10.76 in pre-market trading. eHi Car Services posted Q1 earnings of $0.06 on sales of $89.43 million.
    Skyworks Solutions Inc (NASDAQ: SWKS) rose 5.9 percent to $114.79 in pre-market trading after gaining 0.69 percent on Friday.
    Sorl Auto
  • [By ]

    Some of our newest plays are getting plenty of attention thanks to the biotech buying spree. Array Biopharma (NASDAQ:ARRY) is an instant winner for you thanks to yesterdays 18% pop. And your core holding XBI continues to rake in the gains.

Best Bank Stocks To Watch Right Now: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Keith Speights]

    In December, I included Jazz Pharmaceuticals (NASDAQ:JAZZ) in a list of the three top healthcare stocks investors were overlooking. At that time, I noted that the biotech stock could be a diamond in the rough with its promising pipeline and low valuation.

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Benzinga News Desk]

    On Wednesday, just 24 hours after Amazon announced its first major sports deal — tying up with the NFL to stream 10 Thursday night games — Alphabet Inc (NASDAQ: GOOGL) laid claim to viewers’ credit cards by debuting YouTube TV, a bundle of 50 major television channels for $35 per month: Link

    ECONOMIC DATA
    March 2017 US Challenger layoffs report 43,310 vs 36,975
    Initial Jobless Claims for Mar 31 234.0K vs 250.0K estimate; Continuing Claims for Mar 24 2.03M vs 2.04M estimate.
    San Francisco Federal Reserve Bank President John Williams is set to speak in Frankfurt at 9:30 a.m. ET.
    The Energy Information Administration’s weekly report on natural gas stocks is schedule for release at 10:30 a.m. ET.
    Data on money supply for the recent week will be released at 4:30 p.m. ET.
    ANALYST RATINGS
    Goldman Sachs initiated Advanced Micro Devices (NASDAQ: AMD) at Sell
    JMP Securities upgraded NetApp (NASDAQ: NTAP) from Market Underperform to Market Perform
    PiperJaffray upgraded Abiomed (NASDAQ: ABMD) from Neutral to Overweight
    Deutsche Bank downgraded T-Mobile (NASDAQ: TMUS) from Buy to Hold
    Mizuho downgraded Jazz Pharmaceuticals (NASDAQ: JAZZ) from Buy to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By Ben Levisohn]

    Jazz Pharmaceuticals (JAZZ) has jumped 6.3% to $149.45 after settling a patent dispute.

    CarMax (KMX) gained 2.4% to $58 after beating earnings and sales forecasts.

  • [By Teresa Rivas]

    Jazz Pharmaceuticals (JAZZ) is trading up nearly 9% Thursday, thanks to its settlement with Hikma Pharmaceuticals over the firms patent dispute.

    Pixabay

    As part of the agreement, Hikma will get to sell a generic version of the drug in question, narcolepsy treatment Xyrem, in 2023, for up to five years, while Jazz will get royalties on those sales.

    Janney Montgomery Scotts Ken Trbovich upgraded the shares from Neutral to Buy on the news, and also increased his price target from $138 to $175. From his note:

    While this comes about three years earlier than previous settlements with other generic filers, it eliminates the risk of an earlier launch. Six months thereafter Hikma may launch its own generic and others may potentially be able to launch as well. Importantly, Jazz will receive a meaningful royalty on sales, retain the right to launch its own AG, and can authorize other AGs after the initial 6-month Hikma period.

    Jazz shares are up 8.9% to $153.2o at recent check.

Best Bank Stocks To Watch Right Now: Viking Therapeutics, Inc.(VKTX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Viking Therapeutics Inc (NASDAQ: VKTX) shares dropped 39 percent to $1.17 after the company priced 7.5 million share offering at $1.25 per share.

  • [By George Budwell]

    Shares of Viking Therapeutics (NASDAQ:VKTX), a clinical-stage biotech developing treatments for endocrine and metabolic disorders,dropped by 30.1% last month,according toS&P Global Market Intelligence. What’s all the fuss about?

  • [By Lisa Levin]

     

    Losers
    DBV Technologies SA – ADR (NASDAQ: DBVT) shares tumbled 50.6 percent to $23.73 after the company disclosed that its peanut allergy trial failed to meet primary endpoint.
    Connecture Inc (NASDAQ: CNXR) shares declined 40.8 percent to $0.290. Connecture reported that it will voluntarily delist from the NASDAQ for OTCQX Market.
    Walter Investment Management Corp (NYSE: WAC) slipped 19.2 percent to $0.410. On Friday, Walter Investment Management disclosed that it has reached an agreement with term lenders and senior noteholders on financial restructuring.
    Eldorado Gold Corp (USA) (NYSE: EGO) shares dropped 15.9 percent to $1.83. Eldorado Gold lowered its production guidance for its Kisladag operation.
    Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) shares fell 15.4 percent to $1.04.
    Future Fintech Group Inc (NASDAQ: FTFT) dropped 13.6 percent to $1.53. Future FinTech reported filing of proxy statement, including proposal for corporate restructuring.
    Concordia International Corp (NASDAQ: CXRX) shares fell 12.3 percent to $0.500 after dipping 38.71 percent on Friday.
    Aemetis Inc (NASDAQ: AMTX) shares declined 11.3 percent to $0.550
    OncoSec Medical Inc (NASDAQ: ONCS) dipped 10.5 percent to $1.12. OncoSec reported a $7.1 million registered direct at-the-market offering at a price of $1.34375 per share.
    Evoke Pharma Inc (NASDAQ: EVOK) shares fell 10.35 percent to $3.08 after the company disclosed 'positive' topline results from comparative exposure pharmacokinetic study for Gimoti.
    Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) shares dropped 9.4 percent to $11.60 as the company disclosed Phase 2 interim 24-week data with pegylated interferon lambda in Hepatitis Delta Virus infection at the American Association for the Study of Liver Diseases Meeting.
    Viking Therapeutics Inc (NASDAQ: VKTX) shares slipped 6.6 percent to $2.80. Viking Therapeutics presented results from proof-of-concept study of VK0214 in in vivo

Best Bank Stocks To Watch Right Now: Pluristem Therapeutics Inc.(PSTI)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
  • [By Lisa Levin]

    Pluristem Therapeutics Inc. (NASDAQ: PSTI) shares dropped 20 percent to $1.12. Pluristem disclosed that it has increased its bought deal offering to $15 million of stock and warrants.